Analysts’ Weekly Ratings Changes for Express Scripts (ESRX)

Several brokerages have updated their recommendations and price targets on shares of Express Scripts (NASDAQ: ESRX) in the last few weeks:

  • 2/2/2018 – Express Scripts was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 1/31/2018 – Express Scripts was upgraded by analysts at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating. They now have a $68.00 price target on the stock.
  • 1/30/2018 – Express Scripts was downgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “underperform” rating. They now have a $77.50 price target on the stock, up previously from $55.80.
  • 1/24/2018 – Express Scripts was given a new $86.00 price target on by analysts at Mizuho. They now have a “hold” rating on the stock.
  • 1/12/2018 – Express Scripts had its “buy” rating reaffirmed by analysts at SunTrust Banks, Inc.. They now have a $95.00 price target on the stock.
  • 1/9/2018 – Express Scripts had its “buy” rating reaffirmed by analysts at Robert W. Baird. They now have a $92.00 price target on the stock, up previously from $81.00.
  • 1/4/2018 – Express Scripts is now covered by analysts at Evercore ISI. They set an “in-line” rating and a $78.00 price target on the stock.
  • 12/22/2017 – Express Scripts was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.
  • 12/21/2017 – Express Scripts was given a new $86.00 price target on by analysts at SunTrust Banks, Inc.. They now have a “buy” rating on the stock.
  • 12/21/2017 – Express Scripts had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
  • 12/15/2017 – Express Scripts was given a new $80.00 price target on by analysts at Jefferies Group LLC. They now have a “buy” rating on the stock.
  • 12/15/2017 – Express Scripts was given a new $68.00 price target on by analysts at Royal Bank of Canada. They now have a “hold” rating on the stock.
  • 12/15/2017 – Express Scripts had its “sell” rating reaffirmed by analysts at Raymond James Financial, Inc..
  • 12/15/2017 – Express Scripts was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $81.00 price target on the stock, up previously from $72.00.
  • 12/14/2017 – Express Scripts was given a new $82.00 price target on by analysts at SunTrust Banks, Inc.. They now have a “buy” rating on the stock.
  • 12/14/2017 – Express Scripts had its price target raised by analysts at Maxim Group from $78.00 to $87.00. They now have a “buy” rating on the stock.
  • 12/14/2017 – Express Scripts was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.

Express Scripts Holding (ESRX) opened at $71.71 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding has a twelve month low of $55.80 and a twelve month high of $83.49. The stock has a market capitalization of $40,614.61, a PE ratio of 11.81, a P/E/G ratio of 0.77 and a beta of 0.93.

In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total value of $262,048.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the sale, the vice president now directly owns 33,715 shares in the company, valued at approximately $2,730,915. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,001 shares of company stock worth $1,249,505. Corporate insiders own 0.68% of the company’s stock.

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Receive News & Ratings for Express Scripts Holding Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply